TABLE 2.
Adjusted hazards of 1-y patient death in each DRI category according to eras (ref: Era 1 [2002–2007])
| Era 2 (2008–2013) | Era 3 (2014–2019) | |||
|---|---|---|---|---|
| aHR (95% CI) | P | aHR (95% CI) | P | |
| Overall ACLF | ||||
| Overall | 0.69 (0.61-0.78) | <0.001 | 0.48 (0.42-0.55) | <0.001 |
| 0 < DRI ≦ 1.2 | 0.90 (0.60-1.36) | 0.623 | 0.60 (0.39-0.94) | 0.025 |
| 1.2 < DRI ≦ 1.6 | 0.64 (0.53-0.76) | <0.001 | 0.39 (0.32-0.48) | <0.001 |
| 1.6 < DRI ≦ 2.0 | 0.92 (0.72-1.17) | 0.483 | 0.70 (0.54-0.90) | 0.005 |
| 2.0 < DRI | 0.68 (0.49-0.94) | 0.019 | 0.61 (0.43-0.87) | 0.006 |
| ACLF-1 and 2 | ||||
| Overall | 0.66 (0.57-0.77) | <0.001 | 0.52 (0.44-0.62) | <0.001 |
| 0 < DRI ≦ 1.2 | 0.73 (0.43-1.23) | 0.236 | 0.66 (0.39-1.14) | 0.137 |
| 1.2 < DRI ≦ 1.6 | 0.70 (0.55-0.90) | 0.005 | 0.47 (0.36-0.63) | <0.001 |
| 1.6 < DRI ≦ 2.0 | 0.91 (0.66-1.26) | 0.572 | 0.80 (0.58-1.12) | 0.197 |
| 2.0 < DRI | 0.62 (0.42-0.92) | 0.016 | 0.51 (0.33-0.78) | 0.002 |
| ACLF-3 | ||||
| Overall | 0.74 (0.61-0.89) | 0.001 | 0.43 (0.35-0.53) | <0.001 |
| 0 < DRI ≦ 1.2 | 1.52 (0.75-3.07) | 0.244 | 0.59 (0.27-1.31) | 0.194 |
| 1.2 < DRI ≦ 1.6 | 0.56 (0.42-0.73) | <0.001 | 0.31 (0.23-0.43) | <0.001 |
| 1.6 < DRI ≦ 2.0 | 0.95 (0.66-1.36) | 0.786 | 0.59 (0.40-0.87) | 0.008 |
| 2.0 < DRI | 0.98 (0.52-1.85) | 0.955 | 0.86 (0.45-1.66) | 0.648 |
| Non-ACLF | ||||
| Overall | 0.69 (0.64-0.75) | <0.001 | 0.47 (0.43-0.52) | <0.001 |
| 0 < DRI ≦ 1.2 | 0.90 (0.66-1.22) | 0.490 | 0.66 (0.48-0.92) | 0.013 |
| 1.2 < DRI ≦ 1.6 | 0.71 (0.62-0.81) | <0.001 | 0.47 (0.40-0.55) | <0.001 |
| 1.6 < DRI ≦ 2.0 | 0.71 (0.62-0.83) | <0.001 | 0.51 (0.44-0.61) | <0.001 |
| 2.0 < DRI | 0.68 (0.57-0.82) | <0.001 | 0.44 (0.36-0.54) | <0.001 |
Bold type indicates statistically significant differences.
ACLF, acute-on-chronic liver failure; aHR, adjusted hazard ratio; CI, confidence interval; DRI, donor risk index.